Abstract
Tumors can trigger specific immune response to tumor-associated antigens but the precise mechanism remains unclear. Since regulatory T-lymphocytes (Treg) play a crucial role in controlling autoimmune responses, the present work was undertaken to test whether dysfunction of Treg cells could be involved in developing autoimmunity in patients with lung cancer.
Original language | English |
---|---|
Pages (from-to) | 633-7 |
Number of pages | 5 |
Journal | Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico |
Volume | 15 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2013 |